Sorted By:

Relevance


Eradication of measles highlights the promise of vaccines in development

PhRMA  |  Blog Post

The news this week from PAHO and WHO showcases the hope vaccines offer patients where such diseases are still prevalent.
http://catalyst.phrma.org/eradication-of-measles-highlights-the-promise-of-vaccines-in-development

In Case You Missed It: Progress and Promise in Alzheimer’s Research

PhRMA  |  Blog Post

.ustream.tv/embed/recorded/67637768/?
http://catalyst.phrma.org/in-case-you-missed-it-progress-and-promise-in-alzheimers-research

ICYMI: Wall Street Journal and Washington Post Say TPP Should Protect Medical Innovation

PhRMA  |  Blog Post

As the Journal states, “[o]f the some 5,600 drugs in the pipeline among TPP nations, some 3,400 are being developed by U.S. companies.” 
http://catalyst.phrma.org/icymi-wsj-and-washington-post-say-tpp-should-protect-medical-innovation

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

To help protect this innovation, we participated in a public hearing that will inform the federal government’s annual “Special 301” review of overseas practices that deny adequate and effective intellectual property protection.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-march-4-2016

Medicare Monday: Who Benefits from Part D Extra Help?

PhRMA  |  Blog Post

  Unfortunately, some have proposed harmful changes to this important Medicare Part D program that would hurt the most vulnerable beneficiaries and jeopardize their access to needed medicines.
http://catalyst.phrma.org/medicare-monday-who-benefits-from-part-d-extra-help

Ask About Adherence: Q&A with The Peter Lamy Center for Drug Therapy and Aging

PhRMA  |  Blog Post

His analysis found that there is a substantial benefit even when taking the healthy adherer effect into consideration – up to $6400 a year per person.
http://catalyst.phrma.org/ask-about-adherence-qa-with-the-peter-lamy-center-for-drug-therapy-and-aging

Industry Support for Exempting FDA User Fees from Sequestration

PhRMA  |  Press Release

PhRMA Contact: Stephanie Fischer, 202-835-3431, sfischer@phrma.org  
https://www.phrma.org/press-release/industry-support-for-exempting-fda-user-fees-from-sequestration

Alabama Clinical Trials Benefit Patients and the Economy

PhRMA  |  Press Release

More than 40 percent of the over 3,400 clinical trials of new medicines the companies have conducted with the state’s research institutions have targeted the most debilitating chronic diseases – cancer, diabetes, heart disease, stroke, asthma and mental illnesses. 
https://www.phrma.org/press-release/alabama-clinical-trials-benefit-patients-and-the-economy

Biopharmaceutical industry is essential to development of Alzheimer’s treatments

PhRMA  |  Blog Post

The need for new Alzheimer’s treatments is acute in order to ease the burden on patients and society.
http://catalyst.phrma.org/biopharmaceutical-industry-is-essential-to-development-of-alzheimers-treatments

Senior Director – Policy and Research

PhRMA  |  PhRMA Career

www.GoBoldly.comwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members.
https://www.phrma.org

Senior Director – State Policy (New England Region)

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members. 
https://www.phrma.org/careers/senior-director-state-policy-new-england-region

Director– Policy and Research

PhRMA  |  PhRMA Career

www.GoBoldly.comwww.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members. 
https://www.phrma.org

Ask About Adherence: Q&A with National Consumers League

PhRMA  |  Blog Post

Throughout this campaign, we have had the opportunity to talk to many consumers and health care professionals across the country.
http://catalyst.phrma.org/ask-about-adherence-–-qa-with-national-consumers-league

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

Counterfeit Drug Penalty Enhancement Act, which was passed out of the House Judiciary Committee yesterday, will bolster criminal sentencing guidelines so that criminals caught selling counterfeit medicine face as much as 20 years imprisonment. 
https://www.phrma.org/press-release/world-anti-counterfeiting-day-puts-spotlight-on-growing-foreign-counterfeit-medicine-threat

Big Changes in Fine Print of Some 2015 Health Plans

Access Better Coverage  |  From Our Network

Members of more than 600 plans will see their medical deductibles increase, while those in about 380 will see their deductibles drop.
http://www.accessbettercoverage.org/social-news/big-changes-in-fine-print-of-some-2015-health-plans

New Report Shows Minnesota Clinical Trials Benefit Patients, State Economy and Science

PhRMA  |  Press Release

More than 400 of the trials are still active and recruiting patients, giving some disease sufferers an additional treatment option to discuss with health care providers and local clinicians conducting clinical research. 
https://www.phrma.org/press-release/new-report-shows-minnesota-clinical-trials-benefit-patients-state-economy-and-science

Canada’s promise doctrine strikes again

PhRMA  |  Blog Post

., 2016 FC 344 (April 1, 2016).
http://catalyst.phrma.org/canadas-promise-doctrine-strikes-again

Fact Check Friday: The Truth about IPR and Biopharmaceutical Patents

PhRMA  |  Blog Post

MYTH: The IPR process is necessary to challenge biopharmaceutical patents.
http://catalyst.phrma.org/fact-check-friday-july-31-2015

Brief of PhRMA as Amicus Curiae in Support of Petitioner

PhRMA  |  Speeches & Communication

Over the past decade, PhRMA’s members have secured FDA approval of more than 300 new medicines.
https://www.phrma.org/public-communication/brief-of-phrma-as-amicus-curiae-in-support-of-petitioner

Medicare Monday: Tampering with the Successful Structure of Part D

PhRMA  |  Blog Post

As you know, Medicare Part D is a successful government program coming in well under initial budget projections ($349 billion less than initial 10-year projections, to be exact) and helping to keep costs low for both taxpayers and beneficiaries.
http://catalyst.phrma.org/medicare-monday-tampering-with-the-successful-structure-of-part-d

Special Edition Fact Check Friday: Why disclosing negotiated discounts and rebates won’t help patients

PhRMA  |  Blog Post

In the competitive marketplace for medicines, large, powerful pharmacy benefit managers (PBMs) negotiate significant discounts and rebates with manufacturers.
http://catalyst.phrma.org/special-edition-fact-check-friday-why-disclosing-negotiated-discounts-and-rebates-wont-help-patients

Foreign Sourced Active Pharmaceutical Ingredients vs. Imported Drugs

PhRMA  |  Blog Post

Kendra stressed that while a prescription drug may contain an active pharmaceutical ingredient sourced from other locations in the world, it is important to know that FDA's strict regulations apply to all aspects of the drug's manufacture, including the use of all ingredients, both active and inactive, that make up an FDA-approved medicine sold in the U.S., no matter where the ingredients are derived from.
http://catalyst.phrma.org/foreign-sourced-active-pharmaceutical-ingredients-vs.-imported-drugs

Canada’s innovation opportunity

PhRMA  |  Blog Post


http://catalyst.phrma.org/canadas-innovation-opportunity

Yet Another Misleading Report on Medicine Prices

PhRMA  |  Blog Post

The report also failed to acknowledge the tremendous benefit new innovative medicines provide to patients, the health care system and society.
http://catalyst.phrma.org/yet-another-misleading-report-on-medicine-prices

Biopharmaceutical Innovation Benefits Many Sectors of Industry

PhRMA  |  Blog Post

To learn more about the behind the scenes contributions to biopharmaceutical development, watch the full video:  
http://catalyst.phrma.org/biopharmaceutical-innovation-benefits-many-sectors-of-industry

You have reviewed the first 275 results out of 427. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next